Neurology - InsightsInsights

Leading
the way.

Testing developed
by Neurologists for Neurologists.

Neurology testing is rapidly evolving with increasing numbers of clinically relevant biomarkers discovered each year. Our laboratory collaborates closely with the practice and is designed to offer the most complex, clinically validated testing. Our disease experts support health care professionals in test selection and result interpretation to ensure proper test utilization and the highest quality of care. These physicians are committed to research and discovery to pave the way for the future of neurology testing.

Results That Matter

We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.

400+

laboratory tests developed for our specialized neurology test menu

169

Neurologists on staff at Mayo Clinic

Testing laboratories performing
neurology testing

24/7

Support from Mayo Clinic
physicians and scientists

Advancing the
science

Novel biomarker discoveries occur at a rapid pace, and we are at the forefront of research that integrates these findings into our testing. We were the first laboratory to develop disease-specific evaluations, and our patient-care experience gives us the expertise to develop tests that deliver clinically relevant answers.

The largest, neurology-specific test menu

Our highly specialized test menu provides answers for everything from the simplest to the most complex cases—and much of this testing is not available anywhere else.

Access to Mayo Clinic expertise

Our highly specialized test menu provides answers for everything from the simplest to the most complex cases—and much of this testing is not available anywhere else.

New Testing for
Pediatric CNS Disorders

Autoimmune encephalopathies and myelitis is increasingly recognized as a cause of CNS disease in children and teens. Andrew McKeon, M.B., B.Ch. M.D., gives an overview of this new test.

Resources

The Latest

Discussions with the Directors

A new episode of "Discussions with the Directors" is available on the topic of paraneoplastic testing - when is it appropriate and what is the way ahead. Listen Now!

By Alyssa Frank • July 9, 2020

CNS Autoimmunity: Disorders, Biomarkers, and Updates

PACE
In this month’s “Virtual Lecture,” Andrew McKeon, M.B., B.Ch., M.D., highlights the rapidly evolving field of autoimmune neurology. The importance of a timely and accurate diagnosis of autoimmune neurological disorders cannot be understated, so it is important that neurologists all understand the patient presentation as well as available testing and treatment options.

By MCL Education • June 2, 2020

Pediatric Autoimmune CNS Disorders Evaluation

PACE
This “Specialty Testing” webinar will address the clinical presentations, evaluation (including diagnostic antibody testing), and treatment of autoimmune pediatric CNS disorders, including encephalitides and myelopathies.

By MCL Education • May 27, 2020

The Role of CSF in Alzheimer’s Disease

Originally presented June 24, 2020
PACE
This "Specialty Testing" webinar will discuss Cerebrospinal fluid (CSF), which has been used in research on Alzheimer's disease for decades. Only recently, have platforms been developed to standardize measurements across laboratories.

By MCL Education • May 1, 2020

Alzheimer’s Disease Evaluation [A Test in Focus]

Currently the diagnosis of probable Alzheimer disease (AD) is made based on clinical symptoms, largely by the exclusion of other causes of dementia, with postmortem evidence of AD pathology required to confirm the diagnosis. Two common neuropathologic features found in the brains of patients with AD are the presence of plaques composed of beta-amyloid (Abeta) peptides and intracellular neurofibrillary tangles containing hyperphosphorylated Tau (tubulin-associated unit) proteins.

By Alyssa Frank • May 1, 2020